Inabata Inabata

X

Find Radio Compass News for Remdesivir

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

https://www.businesswire.com/news/home/20240304530607/en

BUSINESSWIRE
05 Mar 2024

https://www.prnewswire.com/news-releases/redhill-and-us-army-announce-opaganib-and-rhb-107-combinations-with-remdesivir-show-distinct-synergistic-effect-against-ebola-302020104.html

PR NEWSWIRE
20 Dec 2023

https://www.businesswire.com/news/home/20230918133960/en

BUSINESSWIRE
19 Sep 2023

https://www.businesswire.com/news/home/20230823245751/en

BUSINESSWIRE
24 Aug 2023

https://www.businesswire.com/news/home/20230713562695/en

BUSINESSWIRE
14 Jul 2023

http://www.pharmabiz.com/NewsDetails.aspx?aid=159418&sid=2

PHARMBIZ
30 May 2023

https://www.businesswire.com/news/home/20230525005607/en

BUSINESSWIRE
26 May 2023

https://www.fiercepharma.com/pharma/gilead-had-its-best-growth-year-2015-truly-believes-veklury-despite-sinking-sales

Zoey Becker FIERCE PHARMA
03 Feb 2023

https://endpts.com/gilead-quashes-microcap-biotechs-matinas-hope-of-partnering-on-oral-covid-19-drug/

Amber Tong ENDPTS
31 Jan 2023

https://www.gilead.com/news-and-press/press-room/press-releases/2022/9/who-expands-recommendation-for-veklury-remdesivir-to-patients-with-severe-disease-in-latest-update-to-covid19-guideline

PRESS RELEASE
28 Sep 2022

https://endpts.com/study-identifies-covid-19-patients-with-mutations-indicating-remdesivir-resistance/

Zachary Brennan ENDPTS
27 Sep 2022

https://nyulangone.org/news/remdesivir-resistant-version-covid-19-detected-organ-transplant-recipients

NYULANGONE
26 Sep 2022

https://www.nasdaq.com/articles/who-recommends-gileads-gild-veklury-for-severe-covid-19

NASDAQ
19 Sep 2022

https://www.businesswire.com/news/home/20220915006144/en

BUSINESSWIRE
16 Sep 2022

https://www.pharmaceutical-technology.com/news/gilead-veklury-who-recommendation/

PHARMACEUTICAL-TECHNOLOGY
16 Sep 2022

https://www.businesswire.com/news/home/20220915005509/en

BUSINESSWIRE
15 Sep 2022

https://www.europeanpharmaceuticalreview.com/news/173574/trio-of-therapies-reduces-risk-of-death-in-patients-with-severe-covid-19/

EUROPEAN PHARMACEUTICAL REVIEW
11 Aug 2022

https://www.pharmaceutical-technology.com/news/gilead-revenue-q2-2022/

PHARMACEUTICAL-TECHNOLOGY
03 Aug 2022

https://www.businesswire.com/news/home/20220721005784/en

BUSINESSWIRE
22 Jul 2022

https://www.businesswire.com/news/home/20220627005789/en

BUSINESSWIRE
19 Jul 2022

https://www.fiercebiotech.com/biotech/activ-nrx-tanks-peptide-fails-nih-trial-severe-covid-19-patients

N.P. Taylor FIERCEBIOTECH
27 May 2022

https://www.fiercepharma.com/pharma/fda-converts-eua-lillys-olumiant-full-nod-hospitalized-covid-19-patients

K. Dunleavy FIERCEPHARMA
12 May 2022

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-approves-first-covid-19-treatment-young-children

FDA
25 Apr 2022

https://health.economictimes.indiatimes.com/news/pharma/gileads-remdesivir-fails-to-show-benefit-in-european-trial-no-fetus-risk-seen-with-first-trimester-vaccination/90656333

HEALTH ET
05 Apr 2022

https://endpts.com/fda-updates-mercks-covid-19-pill-eua-and-reaffirms-it-should-only-be-used-as-a-last-resort/

Zachary Brennan ENDPTS
19 Feb 2022

https://www.news-medical.net/news/20220214/Researchers-identify-a-powerful-combination-of-antivirals-to-treat-COVID-19.aspx

Emily Henderson MEDICAL NET
14 Feb 2022

https://www.clinicaltrialsarena.com/news/gilead-veklury-variants-studies/

CLINICALTRIALSARENA
14 Feb 2022

https://www.businesswire.com/news/home/20220211005579/en

BUSINESSWIRE
11 Feb 2022

https://www.prnewswire.com/news-releases/redhill-biopharmas-oral-opaganib-reduces-mortality-by-70-given-on-top-of-remdesivir-and-corticosteroids-in-severe-covid-19-301476549.html

PRNEWSWIRE
07 Feb 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/study-reveals-hyperimmune-intravenous-immunoglobulin-doesnt-help-covid-19-patients/articleshow/89173902.cms

ECONOMIC TIMES
28 Jan 2022

https://www.pharmaceutical-technology.com/news/gilead-veklury-fda-approval-covid-19-outpatients/

PHARMACEUTICAL-TECHNOLOGY
25 Jan 2022

https://www.reuters.com/article/us-health-coronavirus-fda-remdesivir/fda-expands-use-of-remdesivir-to-patients-with-high-risk-of-hospitalization-idUSKBN2JV2A7

Leroy Leo REUTERS
22 Jan 2022

http://www.pharmabiz.com/NewsDetails.aspx?aid=145257&sid=1

PHARMABIZ
17 Jan 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-5-2022-1641361383.pdf

FDA
05 Jan 2022

https://pressroom.today/2022/01/28/how-pharma-giants-are-investing-heavily-in-rd-to-develop-patient-friendly-drugs-parmjit-arora-health-biotech/amp/

PRESS RELEASE
04 Jan 2022

https://storypivot.com/health-biotech-remdesivir/

STORYPIVOT
02 Jan 2022

http://www.pharmafile.com/news/600878/veklury-demonstrates-reduced-risk-hospitalisation-high-risk-patients-covid-19

PHARMAFILE
23 Dec 2021

http://www.pharmafile.com/news/600878/veklury-demonstrates-reduced-risk-hospitalisation-high-risk-patients-covid-19

PHARMAFILE
23 Dec 2021

https://www.gilead.com/news-and-press/press-room/press-releases/2021/12/gilead-announces-new-england-journal-of-medicine-publication-of-data-demonstrating-veklury-remdesivir-significantly-reduced-risk-of-hospitalization

PRESS RELEASE
22 Dec 2021

https://www.businesswire.com/news/home/20211216006213/en

BUSINESSWIRE
21 Dec 2021

https://www.clinicaltrialsarena.com/news/nrx-encouraging-safety-zyesami-trial/

CLINICALTRIALSARENA
15 Dec 2021

https://www.fiercepharma.com/manufacturing/gilead-recalls-two-lots-covid-19-drug-veklury-after-investigation-confirms-glass

Fraiser Kansteiner FIERCEPHARMA
07 Dec 2021

https://www.dailymail.co.uk/news/article-10273903/Gilead-recalling-two-lots-remdesivir-complaint-glass-particles-vials.html

DAILYMAIL
04 Dec 2021

https://www.pharmacompass.com/pdf/news/gilead-issues-a-voluntary-nationwide-recall-of-two-lots-of-veklury-remdesivir-1638854460.pdf

FDA
04 Dec 2021

https://www.globenewswire.com/news-release/2021/11/29/2341962/0/en/NRx-Pharmaceuticals-Identifies-Significantly-Higher-Likelihood-of-Surviving-and-Recovering-from-Critical-COVID-19-in-ZYESAMI-aviptadil-Treated-Patients-Previously-Administered-Remd.html

GLOBENEWSWIRE
29 Nov 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=144188&sid=1

PHARMABIZ
24 Nov 2021

https://www.raps.org/news-and-articles/news-articles/2021/11/chmp-recommends-11-new-medicines-for-authorization

Joanne S. Eglovitch RAPS
16 Nov 2021

https://www.forbes.com/sites/siladityaray/2021/11/11/remdesivir-linked-covid-19-mutation-found-in-immunocompromised-patient-researchers-find/?sh=46470a8c125e

FORBES
14 Nov 2021

https://api.drreddys.com/news/dr-reddys-api-team-2021-winner-api-supplier-year-global-generics-biosimilars-awards

PRESS RELEASE
11 Nov 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY